Global Pharma Forecasting Software Market Research Report 2025

Publication ID:

PB505250850

Publication Date:

May 28, 2025

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

IT Services [2]

Computing & Electronics [3]

Description:

The global market for Pharma Forecasting Software was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
North American market for Pharma Forecasting Software is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Pharma Forecasting Software is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Pharma Forecasting Software in Pharmaceutical Companies is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Pharma Forecasting Software include IQVIA, JMP, SAS Institute, Oracle, Inpharmation, J+D Forecasting, ZS Associate, Cognizant, Kinaxis, Axtria, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Pharma Forecasting Software, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pharma Forecasting Software.
The Pharma Forecasting Software market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Pharma Forecasting Software market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pharma Forecasting Software companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
IQVIA
JMP
SAS Institute
Oracle
Inpharmation
J+D Forecasting
ZS Associate
Cognizant
Kinaxis
Axtria
Symphony Health
Manthan
Model N
Sarjen
Koerber Pharma
WNS
SoftGroup
Nanjing Haiwei Pharmaceutical Technology
Segment by Type
Stability Prediction
Formulation and Process Development
Other
Segment by Application
Pharmaceutical Companies
Contract Research Organizations (CROs)
Other
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Pharma Forecasting Software company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pharma Forecasting Software Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Stability Prediction
1.2.3 Formulation and Process Development
1.2.4 Other
1.3 Market by Application
1.3.1 Global Pharma Forecasting Software Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Pharmaceutical Companies
1.3.3 Contract Research Organizations (CROs)
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Pharma Forecasting Software Market Perspective (2020-2031)
2.2 Global Pharma Forecasting Software Growth Trends by Region
2.2.1 Global Pharma Forecasting Software Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Pharma Forecasting Software Historic Market Size by Region (2020-2025)
2.2.3 Pharma Forecasting Software Forecasted Market Size by Region (2026-2031)
2.3 Pharma Forecasting Software Market Dynamics
2.3.1 Pharma Forecasting Software Industry Trends
2.3.2 Pharma Forecasting Software Market Drivers
2.3.3 Pharma Forecasting Software Market Challenges
2.3.4 Pharma Forecasting Software Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Pharma Forecasting Software Players by Revenue
3.1.1 Global Top Pharma Forecasting Software Players by Revenue (2020-2025)
3.1.2 Global Pharma Forecasting Software Revenue Market Share by Players (2020-2025)
3.2 Global Pharma Forecasting Software Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Pharma Forecasting Software Revenue
3.4 Global Pharma Forecasting Software Market Concentration Ratio
3.4.1 Global Pharma Forecasting Software Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pharma Forecasting Software Revenue in 2024
3.5 Global Key Players of Pharma Forecasting Software Head office and Area Served
3.6 Global Key Players of Pharma Forecasting Software, Product and Application
3.7 Global Key Players of Pharma Forecasting Software, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Pharma Forecasting Software Breakdown Data by Type
4.1 Global Pharma Forecasting Software Historic Market Size by Type (2020-2025)
4.2 Global Pharma Forecasting Software Forecasted Market Size by Type (2026-2031)
5 Pharma Forecasting Software Breakdown Data by Application
5.1 Global Pharma Forecasting Software Historic Market Size by Application (2020-2025)
5.2 Global Pharma Forecasting Software Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Pharma Forecasting Software Market Size (2020-2031)
6.2 North America Pharma Forecasting Software Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Pharma Forecasting Software Market Size by Country (2020-2025)
6.4 North America Pharma Forecasting Software Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Pharma Forecasting Software Market Size (2020-2031)
7.2 Europe Pharma Forecasting Software Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Pharma Forecasting Software Market Size by Country (2020-2025)
7.4 Europe Pharma Forecasting Software Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Pharma Forecasting Software Market Size (2020-2031)
8.2 Asia-Pacific Pharma Forecasting Software Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Pharma Forecasting Software Market Size by Region (2020-2025)
8.4 Asia-Pacific Pharma Forecasting Software Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Pharma Forecasting Software Market Size (2020-2031)
9.2 Latin America Pharma Forecasting Software Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Pharma Forecasting Software Market Size by Country (2020-2025)
9.4 Latin America Pharma Forecasting Software Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Pharma Forecasting Software Market Size (2020-2031)
10.2 Middle East & Africa Pharma Forecasting Software Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Pharma Forecasting Software Market Size by Country (2020-2025)
10.4 Middle East & Africa Pharma Forecasting Software Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 IQVIA
11.1.1 IQVIA Company Details
11.1.2 IQVIA Business Overview
11.1.3 IQVIA Pharma Forecasting Software Introduction
11.1.4 IQVIA Revenue in Pharma Forecasting Software Business (2020-2025)
11.1.5 IQVIA Recent Development
11.2 JMP
11.2.1 JMP Company Details
11.2.2 JMP Business Overview
11.2.3 JMP Pharma Forecasting Software Introduction
11.2.4 JMP Revenue in Pharma Forecasting Software Business (2020-2025)
11.2.5 JMP Recent Development
11.3 SAS Institute
11.3.1 SAS Institute Company Details
11.3.2 SAS Institute Business Overview
11.3.3 SAS Institute Pharma Forecasting Software Introduction
11.3.4 SAS Institute Revenue in Pharma Forecasting Software Business (2020-2025)
11.3.5 SAS Institute Recent Development
11.4 Oracle
11.4.1 Oracle Company Details
11.4.2 Oracle Business Overview
11.4.3 Oracle Pharma Forecasting Software Introduction
11.4.4 Oracle Revenue in Pharma Forecasting Software Business (2020-2025)
11.4.5 Oracle Recent Development
11.5 Inpharmation
11.5.1 Inpharmation Company Details
11.5.2 Inpharmation Business Overview
11.5.3 Inpharmation Pharma Forecasting Software Introduction
11.5.4 Inpharmation Revenue in Pharma Forecasting Software Business (2020-2025)
11.5.5 Inpharmation Recent Development
11.6 J+D Forecasting
11.6.1 J+D Forecasting Company Details
11.6.2 J+D Forecasting Business Overview
11.6.3 J+D Forecasting Pharma Forecasting Software Introduction
11.6.4 J+D Forecasting Revenue in Pharma Forecasting Software Business (2020-2025)
11.6.5 J+D Forecasting Recent Development
11.7 ZS Associate
11.7.1 ZS Associate Company Details
11.7.2 ZS Associate Business Overview
11.7.3 ZS Associate Pharma Forecasting Software Introduction
11.7.4 ZS Associate Revenue in Pharma Forecasting Software Business (2020-2025)
11.7.5 ZS Associate Recent Development
11.8 Cognizant
11.8.1 Cognizant Company Details
11.8.2 Cognizant Business Overview
11.8.3 Cognizant Pharma Forecasting Software Introduction
11.8.4 Cognizant Revenue in Pharma Forecasting Software Business (2020-2025)
11.8.5 Cognizant Recent Development
11.9 Kinaxis
11.9.1 Kinaxis Company Details
11.9.2 Kinaxis Business Overview
11.9.3 Kinaxis Pharma Forecasting Software Introduction
11.9.4 Kinaxis Revenue in Pharma Forecasting Software Business (2020-2025)
11.9.5 Kinaxis Recent Development
11.10 Axtria
11.10.1 Axtria Company Details
11.10.2 Axtria Business Overview
11.10.3 Axtria Pharma Forecasting Software Introduction
11.10.4 Axtria Revenue in Pharma Forecasting Software Business (2020-2025)
11.10.5 Axtria Recent Development
11.11 Symphony Health
11.11.1 Symphony Health Company Details
11.11.2 Symphony Health Business Overview
11.11.3 Symphony Health Pharma Forecasting Software Introduction
11.11.4 Symphony Health Revenue in Pharma Forecasting Software Business (2020-2025)
11.11.5 Symphony Health Recent Development
11.12 Manthan
11.12.1 Manthan Company Details
11.12.2 Manthan Business Overview
11.12.3 Manthan Pharma Forecasting Software Introduction
11.12.4 Manthan Revenue in Pharma Forecasting Software Business (2020-2025)
11.12.5 Manthan Recent Development
11.13 Model N
11.13.1 Model N Company Details
11.13.2 Model N Business Overview
11.13.3 Model N Pharma Forecasting Software Introduction
11.13.4 Model N Revenue in Pharma Forecasting Software Business (2020-2025)
11.13.5 Model N Recent Development
11.14 Sarjen
11.14.1 Sarjen Company Details
11.14.2 Sarjen Business Overview
11.14.3 Sarjen Pharma Forecasting Software Introduction
11.14.4 Sarjen Revenue in Pharma Forecasting Software Business (2020-2025)
11.14.5 Sarjen Recent Development
11.15 Koerber Pharma
11.15.1 Koerber Pharma Company Details
11.15.2 Koerber Pharma Business Overview
11.15.3 Koerber Pharma Pharma Forecasting Software Introduction
11.15.4 Koerber Pharma Revenue in Pharma Forecasting Software Business (2020-2025)
11.15.5 Koerber Pharma Recent Development
11.16 WNS
11.16.1 WNS Company Details
11.16.2 WNS Business Overview
11.16.3 WNS Pharma Forecasting Software Introduction
11.16.4 WNS Revenue in Pharma Forecasting Software Business (2020-2025)
11.16.5 WNS Recent Development
11.17 SoftGroup
11.17.1 SoftGroup Company Details
11.17.2 SoftGroup Business Overview
11.17.3 SoftGroup Pharma Forecasting Software Introduction
11.17.4 SoftGroup Revenue in Pharma Forecasting Software Business (2020-2025)
11.17.5 SoftGroup Recent Development
11.18 Nanjing Haiwei Pharmaceutical Technology
11.18.1 Nanjing Haiwei Pharmaceutical Technology Company Details
11.18.2 Nanjing Haiwei Pharmaceutical Technology Business Overview
11.18.3 Nanjing Haiwei Pharmaceutical Technology Pharma Forecasting Software Introduction
11.18.4 Nanjing Haiwei Pharmaceutical Technology Revenue in Pharma Forecasting Software Business (2020-2025)
11.18.5 Nanjing Haiwei Pharmaceutical Technology Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer

Companies Mentioned:

IQVIA
JMP
SAS Institute
Oracle
Inpharmation
J+D Forecasting
ZS Associate
Cognizant
Kinaxis
Axtria
Symphony Health
Manthan
Model N
Sarjen
Koerber Pharma
WNS
SoftGroup
Nanjing Haiwei Pharmaceutical Technology

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂